Effect of Laser photobiomodulation to improve mouth opening in precancerous lesion like Oral Submucous Fibrosis
Phase 3
- Conditions
- Health Condition 1: M798- Other specified soft tissue disorders
- Registration Number
- CTRI/2024/05/067705
- Lead Sponsor
- All India Institute of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Subjects with symptomatic bilateral Moderate OSMF = 18 years of age
2.Subjects who have had no medical, surgical or physical intervention for OSMF at least 3 months prior to participation in this study.
3.Subjects willing to participate in the study
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular pathways does 940nm diode laser photobiomodulation modulate in moderate oral submucous fibrosis (OSF) to improve mouth opening?
How does 940nm diode laser PBM compare to corticosteroid injections in functional outcomes for moderate OSF patients?
What are the key molecular targets identified in CTRI/2024/05/067705 for 940nm diode laser PBM in moderate OSF?
What are the potential adverse events of 940nm diode laser PBM in OSF and their management strategies?
Are there synergistic effects when combining 940nm diode laser PBM with antifibrotic agents like pentoxifylline in OSF treatment?